Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-05

Clinical Trial Update: Aripiprazole Effects on Alcohol Reactivity and Consumption [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating aripiprazole for alcohol reactivity and consumption in individuals with alcohol dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence | Phase 2 | Status: COMPLETED